title: Plasmin and the thrombin-thrombomodulin complex both contribute to thrombin-activatable fibrinolysis inhibitor activation in whole blood model thrombi.
authors.affiliation: Laboratory for Pharmaceutical Biology, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
authors.forename: E
authors.initials: E
authors.lastname: Vercauteren
authors.forename: N J
authors.initials: NJ
authors.lastname: Mutch
authors.forename: P J
authors.initials: PJ
authors.lastname: Declerck
authors.forename: A
authors.initials: A
authors.lastname: Gils
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D025901:Carboxypeptidase B2 / Q000037:antagonists & inhibitors / Q000097:blood*; D004789:Enzyme Activation; D005341:Fibrinolysin / Q000378:metabolism*; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D013917:Thrombin / Q000378:metabolism*; D018180:Thrombomodulin / Q000378:metabolism*; D013927:Thrombosis / Q000097:blood*; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; C546931:THBD protein, human; D018180:Thrombomodulin; D025901:Carboxypeptidase B2; D013917:Thrombin; D005341:Fibrinolysin